{"disease":{"id":"cushing-disease","name":"cushing disease"},"drugs":{"marketed":[{"drug_id":"osilodrostat","indication_name":"Pituitary-dependent Cushing's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Isturisa","generic_name":"OSILODROSTAT","company_name":"Recordati","drug_phase":"marketed","molecular_target":"Cytochrome P450 11B2, mitochondrial","drug_class":"Cortisol Synthesis Inhibitor","quality_score":70,"revenue":"200","mechanism":"Isturisa blocks the production of cortisol in the adrenal glands by inhibiting the cytochrome P450 11B2 enzyme."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03575247","title":"The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":111804,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT00001595","title":"An Investigation of Pituitary Tumors and Related Hypothalmic Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT03474601","title":"Seoul National University Pituitary Disease Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":1600,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT00001452","title":"Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex","phase":"","overall_status":"COMPLETED","enrollment_count":1387,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT03831958","title":"Long-Term Follow-Up of Survivors of Pediatric Cushing Disease","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT01794793","title":"Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":337,"lead_sponsor_name":"RECORDATI GROUP","has_results":true},{"nct_id":"NCT03364803","title":"Collecting Information About Treatment Results for Patients With Cushing's Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT02060383","title":"Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT01504399","title":"Rhinological Outcomes in Endonasal Pituitary Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":235,"lead_sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","has_results":false},{"nct_id":"NCT04486859","title":"Postoperative Thrombosis Prevention in Patients With CD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":206,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT02310269","title":"Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"RECORDATI GROUP","has_results":true},{"nct_id":"NCT01374906","title":"Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT02180217","title":"Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT01582061","title":"An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05881005","title":"NAC- NAFLD and Cushing","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT00001849","title":"New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":true},{"nct_id":"NCT02568982","title":"Cushing's Disease Complications","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02697734","title":"Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT01915303","title":"Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":68,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04201444","title":"Hair Cortisol and Cushing's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03621280","title":"Open-label Treatment in Cushing's Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Cortendo AB","has_results":true},{"nct_id":"NCT04374721","title":"Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders","phase":"NA","overall_status":"UNKNOWN","enrollment_count":44,"lead_sponsor_name":"University of Roma La Sapienza","has_results":false},{"nct_id":"NCT07108244","title":"Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":43,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03346954","title":"Impact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03111810","title":"Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT01331239","title":"Safety and Efficacy of LCI699 in Cushing's Disease Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT02603653","title":"Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT05307328","title":"SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Sparrow Pharmaceuticals","has_results":false},{"nct_id":"NCT04569591","title":"DDAVP for Pituitary Adenoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":22,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT07463625","title":"Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT00171951","title":"Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06471829","title":"A Trial of Lu AG13909 in Adult Participants With Cushing's Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"H. Lundbeck A/S","has_results":false},{"nct_id":"NCT06701838","title":"Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT00881283","title":"Long-term Cardiovascular Risk in Cured Cushing's Patients","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04339751","title":"Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}